FDA looks to industry for help in DSCSA compliance

Although pharma manufacturers and contract packagers are ramping up their capital-equipment purchases to meet the November 2017 deadline for having item-level serialization, many aspects of the Drug Supply Chain Security Act (DSCSA) remain unresolved. Some of these are operational issues […]

Read More

Prepaid cash cards motivate clinical trial patients

As the pharma industry makes its peace with the US Physicians Sunshine Act and regulatory reporting of “transfers of value” to healthcare providers—and as the same sort of transparency rules are coming into force in Europe—another transactional channel is getting […]

Read More

Call it the United Nations of Veeva OpenData

The biggest number we’ve seen yet for a global database of healthcare providers (HCPs)—over 19 million—is now available for clients of Veeva’s OpenData service, according to the company. The list, which starts with Armenia and ends with Uzbekistan, includes essentially […]

Read More

Use data analytics to monitor 340B discount drug pricing

Chart 1. Ship-To and Bill-To Hierachies Traditionally, pharma managers responsible for managed markets, government price and corporate finance have paid more attention to bellwether government drug programs such as Medicaid, Medicare and the Federal Supply Schedule. As the industry refocuses […]

Read More

Five tips to protect pharma brands online

MarkMonitor, a ThomsonReuters company based in San Francisco, has had a business for many years of monitoring corporate brands as they appear online in discussion boards e-commerce or other forms of online transactions. Such brandname surveillance is a common activity […]

Read More